logo

For the Inventor, By the Inventor

Yongin, South Korea

Hyung Chul Ryu

This inventor holds 13 USPTO granted patents. Top assignees: Cj Corporation, Cheiljedang Corp., Cj Cheiljedang Corporation. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung Chul Ryu. Retrieved from https://idiyas.com/inventor/hyung-chul-ryu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 23.1

Average Co-Inventor Count = 12.0

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Gyeonggi-Do, KR (2003 - 2005)
  • Yongin, KR (2004 - 2010)

Company Filing History:

goldMedal8 out of 53 
 
Cj Corporation
 patents
silverMedal4 out of 34 
 
Cheiljedang Corp.
 patents
bronzeMedal1 out of 977 
 
Cj Cheiljedang Corporation
 patents

Years Active: 2003-2010

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7781592 - Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same (2010-08-24),
2. 7473700 - 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same (2009-01-06),
3. 7230010 - 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same (2007-06-12),
4. 7019144 - 1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same (2006-03-28),
5. 6967213 - Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same (2005-11-22),
6. 6849652 - 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same (2005-02-01),
7. 6777434 - Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same (2004-08-17),
8. 6768019 - 3,4-dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor (2004-07-27),
9. 6727268 - 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same (2004-04-27),
10. 6689805 - Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same (2004-02-10),
11. 6686493 - 3,4-dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor (2004-02-03),
12. 6599929 - 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor (2003-07-29),
13. 6583321 - 4′-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor (2003-06-24),

Title: The Innovative Path of Inventor Hyung Chul Ryu

Introduction: Hyung Chul Ryu, based in Yongin, South Korea, is a remarkable inventor renowned for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, his work continues to impact the medical and scientific communities.

Latest Patents: Ryu's recent innovations include patents for a thione derivative, which outlines a method for its preparation and a pharmaceutical composition that utilizes this derivative or a non-toxic salt as an active ingredient. Additionally, he has developed a 1,2,4-triazole derivative, including its preparation method and application in pharmaceutical compositions. These advancements showcase his expertise in creating valuable compounds for medical treatments.

Career Highlights: Throughout his career, Hyung Chul Ryu has worked with notable companies such as CJ Corporation and Cheiljedang Corporation. His role in these organizations has allowed him to collaborate on various innovative projects, enhancing the field of pharmaceutical research and development.

Collaborations: Ryu has collaborated with esteemed colleagues including Ji Young Noh and Jong Hoon Kim. These partnerships have not only fostered creativity but have also led to significant developments in their respective areas of research.

Conclusion: Hyung Chul Ryu's journey as an inventor demonstrates his commitment to innovation in the pharmaceutical industry. With a strong portfolio of patents and fruitful collaborations, he continues to pave the way for new breakthroughs that can improve health outcomes around the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…